Focus: Once-daily, potent, brain-penetrant, selective c-Abl kinase inhibitor; monoclonal antibody
ABLi Therapeutics is a life sciences company focused on Once-daily, potent, brain-penetrant, selective c-Abl kinase inhibitor; monoclonal antibody.
Funding Stage
PUBLIC
Open Jobs
0
Open Jobs (0)
No open positions listed yet.